UniProt | Protein Name |
---|---|
O75787 |
|
GO Term | Evidence Code | PMID |
---|---|---|
Golgi lumen acidification |
|
|
synaptic vesicle lumen acidification | ||
central nervous system maturation | ||
head morphogenesis | ||
angiotensin maturation |
GO Term | Evidence Code | PMID |
---|---|---|
plasma membrane | ||
membrane | ||
lysosomal membrane | ||
vacuolar proton-transporting V-type ATPase complex | ||
synaptic vesicle membrane |
GO Term | Evidence Code | PMID |
---|---|---|
signaling receptor activity | ||
protein binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:3620 | central nervous system cancer | |
DOID:3683 | lung benign neoplasm | |
DOID:3770 | pulmonary fibrosis | |
DOID:3840 | craniopharyngioma | |
DOID:3846 | adamantinous craniopharyngioma | |
DOID:3847 | papillary craniopharyngioma | |
DOID:3904 | bronchus carcinoma | |
DOID:3905 | lung carcinoma | |
DOID:4028 | angioma serpiginosum | |
DOID:409 | liver disease |
HPO ID | HPO Term |
---|---|
HP:0000047 | Hypospadias |
HP:0000298 | Mask-like facies |
HP:0000338 | Hypomimic face |
HP:0000341 | Narrow forehead |
HP:0000347 | Micrognathia |
HP:0000369 | Low-set ears |
HP:0000750 | Delayed speech and language development |
HP:0000952 | Jaundice |
HP:0000973 | Cutis laxa |
HP:0001249 | Intellectual disability |
Disease ID | Disease Name |
---|---|
ORPHA:363654 |
|
OMIM:300911 |
|
OMIM:301045 |
|
OMIM:300423 |
|
ORPHA:93952 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
118898556 | BALMU23340 | ||
100665148 | LOXAF06611 | ||
100514935 | PIGXX37169 | ||
513520 | BOVIN37224 | ||
102173826 | CAPHI30823 | ||
100344856 | RABIT13421 | ||
100768578 | CRIGR00616 | ||
70495 | MGI:1917745 | MOUSE66510 | |
302526 | RGD:1561269 | RATNO44552 | |
100732838 | CAVPO14397 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024